Claims for Patent: 7,662,407

Summary for Patent: 7,662,407

Title:	Modified release formulations of a bupropion salt
Abstract:	The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
Inventor(s):	Oberegger; Werner (Mississauga, CA), Maes; Paul (Toronto, CA), Jackson; Graham (Co. Kildare, IE), Saleh; Mohammad Ashty (Oakville, CA)
Assignee:	Biovail Laboratories International S.R.L. (St. Michael, BB)
Application Number:	11/766,251
Patent Claims:	1. A controlled release composition comprising: a core comprising a therapeutically effective amount of bupropion hydrobromide; and a controlled release polymeric coat comprising a water-insoluble polymer and a water-soluble polymer. 2. A controlled release composition comprising: a therapeutically effective amount of bupropion hydrobromide; and a controlled release polymeric coat comprising a water-insoluble polymer, a water-soluble polymer, and a plasticizer. 3. The controlled release composition of claim 2, wherein the ratio of water-insoluble polymer:plasticizer:water-soluble polymer is from about 3:1:4 to about 5:1:2. 4. The controlled release composition of claim 2, wherein the water-insoluble polymer is ethylcellulose; the water-soluble polymer is selected from the group consisting of polyvinylpyrrolidone, hydroxypropyl methylcellulose, hydroxypropyl cellulose, and mixtures thereof; and the plasticizer is selected from the group consisting of dibutyl sebacate, polyethylene glycol 4000, and mixtures thereof. 5. A controlled release composition comprising: a core comprising a therapeutically effective amount of bupropion hydrobromide; and a controlled release polymeric coat.